CIDP (chronic inflammatory demyelinating polyneuropathy) trials in Belgium
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Where
- Anderlecht, Brussels
- Age
- 18 years to 75 years
- People
- 256 worldwide
- Run by
- Dianthus Therapeutics
See details and how to joinNCT06858579 - Phase 3Taking peopleA Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Gent, Leuven
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Sanofi
See details and how to joinNCT06290141 · EU 2023-508338-33-00 - Phase 2Taking peopleImeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Leuven
- Age
- 18 years and over
- People
- 162 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07032662 · EU 2024-517614-14-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Where
- Anderlecht, Liège
- Age
- 18 years and over
- People
- 138 worldwide
- Run by
- Dianthus Therapeutics Inc.
See details and how to join2024-517529-26-00 · EU 2024-517529-26-00 - No phaseTaking peopleExploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.
- Where
- Liège
- Age
- 18 years to 99 years
- People
- 40
- Run by
- Centre Hospitalier Universitaire de Liege
See details and how to joinNCT06183645